IDEAYA Biosciences, Inc.
IDYANasdaqCIK 1676725HealthcareFiscal year ends Dec 31
Reports and events: 150 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0420:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-332774 |
| 2026-08-0410:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331381 |
| 2026-06-2320:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-279427 |
| 2026-06-1020:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-265833 |
| 2026-06-0310:01 ET | 8-K | 8.01 Other events | 0001193125-26-254476 |
| 2026-06-0120:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-251399 |
| 2026-05-0521:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-206806 |
| 2026-05-0520:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-206357 |
| 2026-05-0510:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204944 |
| 2026-04-2920:05 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001193125-26-191501 |
| 2026-04-1310:05 ET | 8-K | 8.01 Other events | 0001193125-26-151893 |
| 2026-04-0910:01 ET | 8-K | 8.01 Other events | 0001193125-26-148777 |
| 2026-02-1721:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-054533 |
| 2026-02-1711:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-052741 |
| 2026-01-1211:11 ET | 8-K | 8.01 Other events | 0001193125-26-009653 |
| 2026-01-1211:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009641 |
| 2025-12-1221:05 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-25-317541 |
| 2025-12-0521:19 ET | 8-K | 8.01 Other events | 0001193125-25-309716 |
| 2025-11-0421:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-264632 |
| 2025-11-0411:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263383 |
| 2025-10-2020:05 ET | 8-K | 8.01 Other events | 0001193125-25-243558 |
| 2025-09-0810:08 ET | 8-K | 8.01 Other events | 0001193125-25-197605 |
| 2025-09-0210:02 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-193238 |
| 2025-08-0520:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102967 |
| 2025-08-0510:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102353 |
| 2025-06-2720:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-151257 |
| 2025-06-2421:27 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-145830 |
| 2025-05-0620:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064438 |
| 2025-05-0610:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063938 |
| 2025-04-3010:06 ET | DEF 14A | Proxy statementPeriod 2025-06-24 | 0000950170-25-060530 |
| 2025-04-0220:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-071309 |
| 2025-02-1821:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-022183 |
| 2025-02-1311:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-019314 |
| 2025-02-1011:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-023076 |
| 2024-12-3011:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-286169 |
| 2024-11-0421:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-120675 |
| 2024-11-0411:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-120257 |
| 2024-10-2510:04 ET | 8-K | 8.01 Other events | 0001193125-24-243413 |
| 2024-10-0420:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-233038 |
| 2024-09-2310:12 ET | 8-K | 8.01 Other events | 0001193125-24-223230 |
| 2024-08-0620:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091823 |
| 2024-08-0620:01 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0001193125-24-194852 |
| 2024-08-0610:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091175 |
| 2024-07-3110:03 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-088200 |
| 2024-07-1120:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-177726 |
| 2024-07-0920:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001193125-24-176736 |
| 2024-07-0810:04 ET | 8-K | 8.01 Other events | 0001193125-24-175867 |
| 2024-06-2710:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-169573 |
| 2024-06-0310:05 ET | 8-K | 8.01 Other events | 0000950170-24-067644 |
| 2024-05-3120:54 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-067407 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.